tirzepatide shortage FDA reconsidering its decision to take off its drug list Tirzepatide Update: On December 19th

During the first 4 weeks, you may notice mild appetite changes and early side effects like nausea, bloating, diarrhea, constipation, and gastrointestinal problems

Cardiometabolic markers (TRIUMPH-1, 80 weeks) This profile reads more like metabolic reprogramming than appetite suppression: Triglycerides: 41.0% Non-HDL cholesterol: 24.2% Systolic blood pressure: 12.3 mmHg Waist circumference: 24.1 cm (9.5 inches) What to Watch For: The Most Common Side Effects Retatrutides safety profile is broadly consistent with the GLP-1 class, with one genuinely new signal

In hypertension and heart failure, mitochondrial dysfunction in autonomic ganglia leads to impaired vagal tone and sympathetic overactivity, which in turn exacerbates cardiac remodeling and cerebral hypoperfusion

Referral to reproductive endocrinology (for women) or urology (for men) may be appropriate